Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease

International Journal of Neuroscience

Volumn 116, Issue 12, 2006, Pages 1391-1402

  Shukla, R ^a   Rajani, M ^a   Srivastava, N ^b   Barthwal, M K ^b   Dikshit, M ^b  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Cerebrospinal fluid; Lipid peroxidation; Nitric oxide; Oxidative stress; Parkinson's disease

Indexed keywords

ALPHA TOCOPHEROL; AMANTADINE; CARBIDOPA PLUS LEVODOPA; MALONALDEHYDE; NITRIC OXIDE; NITRITE; SELEGILINE; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PARKINSON DISEASE;

FEMALE; FREE RADICALS; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; OXIDATIVE STRESS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 33845488557     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450500513989     Document Type: Article

References (30)

1. Agid, Y. (2001). Levodopa: Is toxicity a myth?. Neurology, 57(10 Suppl 3), S46-S51.
2. Barthwal, M. K., Srivastava, N., Shukla, R., Nag, D., Seth, P. K., Srimal, R. C., & Dikshit, M. (1999). Polymorphonuclear leukocyte nitrite content and antioxidant enzymes in Parkinson's disease patients. Acta Neurologica Scandinavia, 100(5), 300-304.
3. Beal, M. F. (1998). Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Annals of Neurology, 44(3 Suppl 1), S110-S114.
4. Bredt, D. S., & Snyder, S. H. (1994). Nitric oxide: A physiological messenger molecule. Annual Review of Biochemistry, 63, 175-195.
5. Calne, D. B. (2000). Parkinson's disease is not one disease. Parkinsonism and Related Disorders, 7(1), 3-7.
6. Calne, D. B., Snow, B. J., & Lee, C. (1992). Criteria for diagnosing Parkinson's disease. Annals of Neurology, 32(Suppl), S125-S127.
7. Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P., & Marsden, C. D. (1989). Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. Journal of Neurochemistry, 52(2), 381-389.
8. Fahn, S., Elton, R. L., & Members of the UPDRS Development Committee. (1987). The Unified Parkinson's disease Rating Scale. In S. Fahn, C. D. Marsden, D. B. Calne, & M. Goldstein (Eds.), Recent developments in Parkinson's disease. (pp. 153-163). Florham Park, N. J.: Macmillan Healthcare.
9. Gatto, E. M., Riobo, N. A., Carreras, M. C., Schopfer, F. J., Pargament, G. A., & Poderoso, J. J. (1999). Circulating plasma factors in Parkinson's disease enhance nitric oxide release of normal human neutrophils. Journal of Neurological Sciences, 165(1), 66-70.
10. Gatto, E. M., Riobo, N. A., Carreras, M. C., Chernavsky, A., Rubio, A., Satz, M. L., & Poderoso, J. J. (2000). Overexpression of neutrophil nitric oxide synthase in Parkinson's disease. Nitric Oxide, 4(5), 534-539.
11. Gerlach, M., Blum-Degen, D., Lan, J., & Riederer, P. (1999). Nitric oxide in the pathogenesis of Parkinson's disease. In G. M. Stern (Ed.), Parkinson's disease. Advances in Neurology. (pp. 239-245). Philadelphia: Lippincott Williams & Wilkins.
12. Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17(5), 427-442.
13. Ilic, T. V., Jovanovic, M., Jovicic, A., & Tomovic, M. (1999). Oxidative stress indicators are elevated in de-novo Parkinson's disease patients. Functional Neurology, 14(3), 141-147.
14. Jenner, P. (1998). Oxidative mechanisms in nigral cell death in Parkinson's disease. Movement Disorders, 13(Suppl 1), 24-34.
15. Kalra, J., Rajput, A. H., Mantha, S. V., Chaudhary, A. K., & Prasad, K. (1992). Oxygen free radical producing activity of neutrophils in patients with PD. Molecular and Cellular Biochemistry, 112(2), 181-186.
16. Kuiper, M. A., Visser, J. J., Bergmans, P. L., Scheltens, P., & Wolters, E. C. (1994). Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients. Journal of Neurological Sciences, 121(1), 46-49.
17. Kurtzke, J. F. (1984). Neuroepidemiology. Annals of Neurology, 16(3), 265-277.
18. 2/and NO flux. Analusis, 28, 493-505.
19. Molina, J. A., Jimenez-Jimenez, F. J., Navarro, J. A., Riuz, E., Arenas, J., Cabrera-Valdivia, F., Vazquez, A., Fernandez-Calle, P., Ayuso-Perlta, L., Rabasa, M., & Bermejo, F. (1994). Plasma levels of nitrates in patients with Parkinson's disease. Journal of Neurological Sciences, 127(1), 87-89.
20. Molina, J. A., Jimenez-Jimenez, F. J., Navarro, J. A., Vargas, C., Gomez, P., Benito-Leon, J., Orti-Pareja, M., & Cisneros, E. (1996). Cerebrospinal fluid nitrate levels in patients with Parkinson's disease. Acta Neurologica Scandenavia, 93(2-3), 123-126.
21. Mordvintcev, P., Mulsch, A., Busse, R., & Vanin, A. (1991). Online detection of nitric oxide formation in liquid aqueous phase by electron para-magnetic resonance spectroscopy. Analytical Biochemistry, 199(1), 142-146.
22. Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Analytical Biochemistry, 95(2), 351-358.
23. Qureshi, G. A., Baig, S., Bednar, I., Sodersten, P., Forsberg, G., & Siden, A. (1995). Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease. Neuroreport, 6(12), 1642-1644.
24. Sanchez-Ramos, J. R., Overvik, E., & Ames, B. N. (1994). A marker of oxyradical mediated DNA (8-hydroxy-2′ deoxyguanosine) is increased in nigrostriatum of Parkinson's disease brain. Neurodegeneration, 3(2), 197-204.
25. Sethi, S., Singh, M. P., & Dikshit, M. (1999). Nitric oxide mediated augmentation of polymorphonuclear free radical generation following hypoxia and reoxygenation. Blood, 93(1), 330-340.
26. Wallerath, T., Gath, I., Aulitzky, W. E., Pollock, J. S., Kleinert, H., & Fostermann, U. (1997). Identification of NO synthase isoforms expressed in human neutrophil granulocytes,megakaryocytes and platelets. Thrombosis Haemostasis, 77(1), 163-167.
27. Wennmalm, A., Benthin, G., & Petersson, A. S. (1992). Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. British Journal of Pharmacology, 106(3), 507-508.
28. Yamada, K., Nishiwaki, K., Haltori, K., Senzabi, K., Nagata, M., Komatsu, T., Shimada, Y., & Nabeshima, T. (1997). No changes in cerebrospinal fluid levels of nitrite, nitrate and cyclic GMP with aging. Journal of Neural Transmission, 104(8-9), 825-831.
29. Zecca, L., Rosati, M., Renella, R., Gaimberti, M., Ambrosini, A., & Farcells, R. G. (1998). Nitrite and nitrate levels in cerebrospinal fluid of normal subjects. Journal of Neural Transmission, 105, 627-633.
30. Zhang, Y., Dawson, V. L., & Dawson, T. M. (2000). Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiology of Disease, 7(4), 240-250.